The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study
A randomized, controlled trial of oral propranolol in infantile hemangioma.
Oral propranolol has been used to treat complicated infantile hemangiomas, although data from randomized, controlled trials to inform its use are limited. ⋯ This trial showed that propranolol was effective at a dose of 3 mg per kilogram per day for 6 months in the treatment of infantile hemangioma. (Funded by Pierre Fabre Dermatologie; ClinicalTrials.gov number, NCT01056341.).
-
Letter Case Reports
Viremic relapse after HIV-1 remission in a perinatally infected child.